Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway Cover

.blurhash-client-img { display: none !important; }

Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway

Acta Pharmaceutica

Volume 75 (2025): Issue 3 (September 2025)

By: Xiao-Wei Li, Yun-Fei Chen, Lan Zhou, Peng Zhou, Peng Huang, Qian Niu and Jin-Cai Li

Open Access

|Oct 2025

Authors

Xiao-Wei Li

Pharmacy Department, Mengcheng Hospital of Traditional Chinese Medicine, China

Yun-Fei Chen

Pharmacy Department, Mengcheng Hospital of Traditional Chinese Medicine, China

Lan Zhou

Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, China

Peng Zhou

Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, China

Peng Huang

Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, China

Qian Niu

ahniuqian@bzy.edu.cn

Department of Pharmacy, Bozhou Vocational and Technical College Bozhou, China

Jin-Cai Li

ahbanli@bzuu.edu.cn

School of Traditional Chinese Medicine, Bozhou University Bozhou, Anhui, China

DOI: https://doi.org/10.2478/acph-2025-0025 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 517 - 530

Accepted on: Jun 24, 2025

Published on: Oct 10, 2025

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

NLRP3/caspase-1/GSDMD signalling pathway

Related subjects:

Pharmacy, other

© 2025 Xiao-Wei Li, Yun-Fei Chen, Lan Zhou, Peng Zhou, Peng Huang, Qian Niu, Jin-Cai Li, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 75 (2025): Issue 3 (September 2025)Next article